Sign up for a daily newsletter defining what matters in business and markets


Drug pricing's "double whammy" for patients with chronic illnesses

Rising deductibles paired with the rising cost of medications for chronic conditions has left middle-income Americans saddled with debt and skipping out on their treatment, the L.A. Times reports.

Why it matters: Care for conditions like cancer, diabetes and epilepsy— which require regular treatment, including drugs— are costing the insured thousands of dollars a year, a major shift from when deductibles were lower or nonexistent.

  • "That has made being sick in the U.S. dramatically more expensive," the Time's Noam Levey writes.

For example: One recent study found that in 2016, people taking multiple sclerosis drugs paid, on average, $3,708 in out-of-pocket costs for the drugs each year. The cost for patients with high deductible plans was, on average, almost $8,000 a year.

  • But 15 years ago, the average out-of-pocket cost for these drugs was $244.

The bottom line: When patients ration their own care to try to save money, it puts their health — and even their lives — at risk.

Go deeper: How chronic conditions drive up health spending